Cited by 321Cancer Risks and FactorsMenopause: Health Impacts and TreatmentsEndometrial and Cervical Cancer Treatments

The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

Crosbie, Emma J., Zwahlen, Marcel, Kitchener, Henry C., Egger, Matthias, Renehan, Andrew G.·2010·Cancer Epidemiology, Biomarkers & Prevention

DOI 10.1158/1055-9965.epi-10-0832

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Background: Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type. Methods: We searched MEDLINE and EMBASE (1966 to December 2009) to identify prospective studies of BMI and incident endometrial cancer. We did random-effects meta-analyses, meta-regressions, and generalized least square regressions for trend estimations assuming linear, and piecewise linear, relationships. Results: Twenty-four studies (17,710 cases) were analyzed; 9 studies contributed to analyses by HRT, menopausal status, or histologic type, all published since 2003. In the linear model, the overall risk ratio (RR) per 5 kg/m2 increase in BMI was 1.60 (95% CI, 1.52–1.68), P < 0.0001. In the piecewise model, RRs compared with a normal BMI were 1.22 (1.19–1.24), 2.09 (1.94–2.26), 4.36 (3.75–5.10), and 9.11 (7.26–11.51) for BMIs of 27, 32, 37, and 42 kg/m2, respectively. The association was stronger in never HRT users than in ever users: RRs were 1.90 (1.57–2.31) and 1.18 (95% CI, 1.06–1.31) with P for interaction = 0.003. In the piecewise model, the RR in never users was 20.70 (8.28–51.84) at BMI 42 kg/m2, compared with never users at normal BMI. The association was not affected by menopausal status (P = 0.34) or histologic type (P = 0.26). Conclusions: HRT use modifies the BMI-endometrial cancer risk association. Impact: These findings support the hypothesis that hyperestrogenia is an important mechanism underlying the BMI-endometrial cancer association, whilst the presence of residual risk in HRT users points to the role of additional systems. Cancer Epidemiol Biomarkers Prev; 19(12); 3119–30. ©2010 AACR.

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-10-0832

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Self-citation
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
(2005) · The Lancet · doi:10.1016/s0140-6736(05)66544-0 · Cited by 7,626
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
Marmot, M. G., Atinmo, T., Byers, T., Chen, J., Hirohata, T., Jackson, A., James, W., Kolonel, L. N., Kumanyika, S., Leitzmann, C., et al. (2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,368
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citation
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,508
Case-Control Studies: Design, Conduct, Analysis.
Youkeles, L., & Schlesselman, J. J. (1983) · Journal of the American Statistical Association · doi:10.2307/2288156 · Cited by 2,358

Show all 85 references

Research works printed but not linked: 2

World Health Organisation, BMI classification
Tobias, 1999, sbe26: Assessing the influence of a single study in meta-analysis, Stata Tech Bull, 47, 15

Sorted by citations

Items 201–300 of 321

Einfluss endogener und exogener Hormone in der Peri- und Postmenopause auf das Krebsrisiko
Schüler‐Toprak, S., Bausewein, L., & Ortmann, O. (2025) · Die Gynäkologie · doi:10.1007/s00129-025-05345-y · Cited by 5
Betulinic acid and obesity-related disorders
Azevedo, L. F., Ferraz, R., Vieira, M., Prudêncio, C., & Fernandes, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1674713 · Cited by 6
Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA
Chang, O. H., & Ferrando, C. A. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.07.006 · Cited by 5
Minimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer: Epigenetic Insights and the Promise of DNA Methylation
Porcaro, F., Paolucci, A., Porcaro, P., Cardinale, G., Romitelli, A., Cozzolino, D., & Voccola, S. (2024) · Diagnostics · doi:10.3390/diagnostics14222575 · Cited by 5
The Current and Future States of Screening in Gynecologic Cancers
Lee, J. K., & Nair, N. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.06.001 · Cited by 5
Hormones and risk of breast and gynecological cancer
Schüler‐Toprak, S., Seitz, S., & Ortmann, O. (2017) · Der Gynäkologe · doi:10.1007/s00129-016-4004-0 · Cited by 5
“The positive correlation of BMI and endometrial cancer risk was shown in several studies in recent years [34, 37, 51, 53, 62, 79, 140, 183, 210, 230].”
Background
Apronectomy combined with laparotomy for morbidly obese endometrial cancer patients
Crosbie, E. J., Raisi‐Estabragh, Z., Murphy, J., Ahmed, A. S., & Slade, R. J. (2011) · Surgical Oncology · doi:10.1016/j.suronc.2011.06.005 · Cited by 5
“This reflects the high average BMI of our cohort, since BMI is known to impact on endometrial cancer risk in a dose-dependent manner [2].”
BackgroundSelf-citation
Endometrial cancer and endometrial changes in transgender men: Insights from Japanese individuals on testosterone
Nakahara, M., Yoshida, H., Sakamoto, A., Taguchi, T., Uno, M., Kato, T., & Ishikawa, M. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16099 · Cited by 4
“27 This risk is further heightened by obesity-associated C-reactive protein (CRP), IL-6, and Tumor Necrosis Factor-α (TNF-α ) elevations and a relative deficiency of defensive immune cells in the endometrium.”
Ethnic and geographic variations in corpus uteri cancer burden: evidence based on data from 29 states and the District of Columbia. CI5 IX, X and SEER data (1998–2010)
Sighoko, D. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0425-z · Cited by 4
“Some of these risk factors such as obesity and parity are modifiable, and their prevalence varies across states and ethnicities in the USA [15–17].”
Review of gynaecological cancer among Aboriginal and/or Torres Strait Islander people in Australia
Powell, A., Morseu-Diop, A., Ninomiya, M. M., Yadav, U. N., Phillips, E., Singh, D. R., Butler, T., Allanson, E., & Whop, L. J. (2023) · Journal of the Australian Indigenous HealthInfoNet · doi:10.14221/2653-3219.1029 · Cited by 4
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Neel, B. A., Antoniou, I. M., Yakar, S., & LeRoith, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_36 · Cited by 4
Obesity is associated with higher 4E-BP1 expression in endometrial cancer
Libby, E. F., Azrad, M., Novak, L., Demark‐Wahnefried, W., Vazquez, A. I., & Wilson, T. R. (2014) · Current Biomarker Findings · doi:10.2147/cbf.s53530 · Cited by 4
“5 Insulin and leptin stimulate the proliferation of EC cells in vitro 6,7 and positively correlate with endometrial cell proliferation rates in the normal tissue of women who are normal weight, overweight, and obese.”
Same-day discharge after minimally invasive hysterectomy for endometrial cancer and endometrial intraepithelial neoplasia in patients with morbid obesity: Safety and potential barriers
Burdette, E. R., Pelletier, A. J., Flores, M. N., Hinchcliff, E., Laurent, J. D. S., & Feltmate, C. M. (2024) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2024.100042 · Cited by 3
Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials
Himpe, J., Orije, M. R. P., Jaeghere, E. A. D., Vandecasteele, K., & Denys, H. G. (2026) · Cancers · doi:10.3390/cancers18020258 · Cited by 3
“Obesity and advancing age are important risk factors contributing to the rising incidence of endometrial cancer, while Lynch syndrome confers a hereditary predisposition to the disease [1,3–5].”
Endometrial cancer patients understanding and interest in weight loss surgery
Wiley, R. L., Urbauer, D. L., Nugent, E. K., Gallegos, J., & Ramondetta, L. M. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.05.068 · Cited by 3
Machine Learning–Predictive Models for Survival in Uterine Cancer Patients With Type 2 Diabetes: A Territory‐Wide Cohort Study
Zhong, C. C., Huang, J., Yang, Z., Li, Z., Yu, J., Yuan, J., Huang, X., Liu, X., Lin, Q., Wang, H., et al. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70087 · Cited by 2
The Influence of Lifestyle Risk Factors on the Occurrence of Gynecological Cancers: A Review of the Evidence and Opportunities for Prevention and Management
Bittoni, M. A., Fisher, J. L., & Weier, R. C. (2015) · International Journal of Cancer Studies & Research · doi:10.19070/2167-9118-si02001 · Cited by 3
A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand
Nanthamongkolkul, K., Taweerat, P., & Jiamset, I. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.22262 · Cited by 3
A new method that facilitates the diagnosis of endometrial cancer: the ratio of endometrial thickness to the full thickness of the uterine wall and subcutaneous adipose tissue measurements
Gök, S., ATIGAN, A., & Gök, B. C. (2024) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2024.136961 · Cited by 3
“Novel observations demonstrate that a 5 kg/m 2 increase in BMI can cause about a 60% increase in the risk of EC [21].”
Background
Quantitative analysis of trends and inequalities in disease burden and care quality of gynecological cancers, 1990–2021
Zhu, X., Feng, X., Yu, S., Qiu, Z., Lou, Y., & Qiu, Z. (2025) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000978 · Cited by 3
Towards Evidence Based M-Health Application Design in Cancer Patient Healthy Lifestyle Interventions
Antoniou, P. E., Rivera-Romero, O., Karagianni, M. A., & Bamidis, P. D. (2017) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2017.117 · Cited by 3
“An increased risk of adenocarcinoma of esophagus, colon and rectal cancer, pancreas cancer, kidney cancer, and endometrial and postmenopausal breast cancer has been associated with excess weight [5], [6], [7], [8].”
Background
Uso de la metformina en cáncer ginecológico
Troconis, N. (2021) · doi:10.47307/gmc.2021.129.1.12 · Cited by 2
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Morton, M. A., McLaughlin, E. M., Calo, C. A., Lightfoot, M. D. S., Bixel, K. L., Cohn, D. E., Cosgrove, C. M., Copeland, L. J., O’Malley, D. M., Nagel, C. I., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.08.009 · Cited by 2
Importance of p53, bcl-2 genes in uterine body cancer and their role in prediction
Исраиловна, Т. Н., Atakhanova, N. E., Almuradova, D. M., Kobilov, O., & Abdinazarova, I. S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.12898 · Cited by 2
Coffee Drinking and Endometrial Cancer
Merritt, M. A., & Gunter, M. J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0112-4 · Cited by 2
Epidemiologic Evidence for the Obesity-Endometrial Cancer Relationship
Merritt, M. A., & Gunter, M. J. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-63483-8_1 · Cited by 2
Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review)
Lengkey, R. F., Soetadji, R. S., & Sanjaya, A. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.263 · Cited by 2
Surpoids, obésité et risque de cancers
Ancellin, R., & Bessette, D. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2261-2 · Cited by 2
Obesity and clinical psychosomatic women’s health
Lal, M., & Sarhadi, A. H. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00032-2 · Cited by 2
Pulmonary metastasis of stage I, low-grade endometrioid carcinoma: two case reports and the literature review
Wang, L., Li, Y., & Han, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1266485 · Cited by 1
A one-stop clinic improvement project for postmenopausal bleeding in NHS Forth Valley
Robinson, A., Wilson, D. J., & Mahal, D. (2025) · BMJ Open Quality · doi:10.1136/bmjoq-2024-003248 · Cited by 1
Mapping the relationship between obesity and endometrial cancer: current research hotspots and future trends (2003-2024)
Liang, L., Song, C., Yang, B., Chang, C., Chen, S., & Sun, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1567022 · Cited by 4
“Research shows that among the 20 most common cancers, EC has the strongest association with obesity; for every 5 kg/m² increase in a patient ’ s BMI, the risk of developing cancer increases by 5.4% (10), with women having a BMI greater than 40 kg/m² facing a 10-15% risk of developing EC (11).”
Influential
Sex and Gender Perspective in Obesity and Gastric Cancer
Kim, N. (2026) · Sex- and Gender-Specific Biomedicine · doi:10.65400/sgbm.2026.1.1.5 · Cited by 1
Impact of hypothyroidism and hyperthyroidism on endometrial cancer incidence: results from a large population-based cohort study
Jensen, A., Nøhr, B., Christensen, J., Gottschau, M., Lindquist, S., Pedersen, J., & Kjær, S. K. (2026) · European Journal of Epidemiology · doi:10.1007/s10654-026-01391-5 · Cited by 1
“The associated risk increases in a non-linear dose–response pattern across the full BMI spectrum, with a particularly pronounced effect observed in the overweight range [45–47].”
Adiposity and cancer: epidemiology, mechanisms and future perspectives
Watts, E. L., Gonzalez‐Feliciano, A. G., Gunter, M. J., Chatterjee, N., & Moore, S. C. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01529-5 · Cited by 2
“Most notably for female reproductive cancers, the magnitude of the obesity association appears to be greater for women who are never-users of hormone replacement therapy, providing further evidence that oestradiol lies on the causal pathway 161–163 .”
Fertility‐Sparing Treatment of Endometrial Cancer: Survey of Australian Practice
Odgers, H. L., & Farrell, R. (2026) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.70176 · Cited by 1
A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer
Bolton, K. A., Avery‐Kiejda, K. A., Holliday, E. G., Attia, J., Bowden, N. A., & Scott, R. J. (2016) · Endocrine Connections · doi:10.1530/ec-16-0003 · Cited by 1
Metabolic Syndrome and Endometrial Cancer
Chandramohan, K. N., & Arun, P. M. (2015) · Springer eBooks · doi:10.1007/978-81-322-1892-0_35 · Cited by 1
Hormonal and Metabolic Strategies to Overcome Insulin Resistance and Prevent Endometrial Cancer
Kitson, S., & Crosbie, E. J. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-63483-8_10 · Cited by 1
Self-citation
Risk Factors for Ovarian Cancer
Zayyan, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.86712 · Cited by 1
Dedifferentiated umbilical metastases from low grade endometrioid endometrial adenocarcinoma complicated by super-obesity: A case report
Odgers, H. L., Anderson, L. A., Kok, P., & Farrell, R. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.108449 · Cited by 1
Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization
Almorox, L., Antequera, L., Rojas, I., Herrera, L. J., & Ortuño, F. M. (2024) · Genes · doi:10.3390/genes15030312 · Cited by 1
“Conversely, in developed countries, uterine corpus cancer stands as the most prevalent gynecological malignancy, surpassing cervical cancer [4,5].”
Background
Uterine Cancer Surgery
Avila, M., & Kotha, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-50977-3_55 · Cited by 1
Consumption of sugary foods and drinks and risk of endometrial and ovarian cancers
King, M. G. (2012) · doi:10.7282/t3wq02kv · Cited by 1
“The role of excess weight in endometrial carcinogenesis is well-known and several studies have reported a direct association between obesity and endometrial cancer risk(8, 23, 24).”
Background
Metformin in ovarian cancer therapy: A discussion
Guo, J., Ouyang, Y., Chen, X., Zhang, C., & Bunyamanop, V. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.189306 · Cited by 1
Diabetes and Cancer: Is there a Link?
Suceveanu, A., Suceveanu, A., Gheorghe, A. D., & Mazilu, L. (2018) · InTech eBooks · doi:10.5772/intechopen.72081 · Cited by 1
Leitliniengerechtes Vorgehen beim Endometriumkarzinom
Domröse, C. M., & Mallmann, P. K. (2019) · Im Focus Onkologie · doi:10.1007/s15015-018-0002-5 · Cited by 1
Assessment of Endometrial Carcinoma Markers and Hormone Receptors Profile before and after Bariatric Surgery: A Clinico-Pathological-Immunohistochemical Study
Elnagar, W. M., Elbasateeny, S. S., Abdelwahab, M. M., Yassin, M. A., Baiomy, T. A., Amin, M. A., & El-Shafei, D. A. (2019) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2019.97099 · Cited by 1
“As a result, females with class III-IV obesity (BMI ≥ 40 kg/m(2) and ≥50 kg/m(2), respectively) will have ten folds higher risk of EC compared to normal weight females [3].”
Background
[Retracted] RUNX3 Expression Level Is Correlated with the Clinical and Pathological Characteristics in Endometrial Cancer: A Systematic Review and Meta‐analysis
Liu, Z., Hong, Z., & Xi, S. (2021) · BioMed Research International · doi:10.1155/2021/9995384 · Cited by 1
“EC is a multifactor process in which the deletion of tumour suppressor genes and the activation of carcinogenesis are particularly important [2, 3].”
Background
Retracted
Aktuelle Diagnostik und Therapie des Endometriumkarzinoms
Dayan, D., Janni, W. J., & Pfister, K. (2022) · Der Gynäkologe · doi:10.1007/s00129-022-04909-6 · Cited by 1
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Neel, B. A., Antoniou, I. M., Yakar, S., & LeRoith, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_36-2 · Cited by 1
The use of panniculectomy in morbidly obese patients undergoing gynecological surgery.
Żyła, M. M., Nowińska-Serwach, A., Nowak, M., Stetkiewicz, T., Wilamowska, A., Szpakowski, A., Litwińska, E., Baum, M., Kajdos, M., Rycel, M., et al. (2014) · PubMed · Cited by 1
Developing HRT Prescribing in Obese Women
Maclaran, K., & Panay, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00039-x
Vitamin D exposure and cancer incidence and mortality, all-cause mortality, and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Murphy, N. (2013) · Spiral (Imperial College London) · doi:10.25560/23895
Obesity, Nutrition, and Cancer in Menopause: European Perspectives
Aleksandrova, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-373-2_22
Energy Imbalance and Cancer Risk
Keum, N. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
PROSPECTS AND CONSEQUENCES OF HORMONE REPLACEMENT THERAPY IN CANCERS A REVIEW
Fatima, S., Noor, S., Maazuddin, M., & Fatima, A. F. (2014) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2014.060201
“[43] Ovarian cancer Knowledge about the impact of menopausal hormone therapy (MHT) on the risk of ovarian cancer (OvC) is insufficient, and studies are inconsistent.”
Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated
Kitchener, H. C., Butler, K. A., Crosbie, E. J., & Mariani, A. (2013) · Springer eBooks · doi:10.1007/978-0-85729-910-9_4
Self-citation
Unopposed Exogenous Estrogen Administration And its Effect on The Histomorphology of Endometrium in Swiss Albino Mice
Gnanagurudasan, E. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-160401122126
“The excess adipose tissue in obesity becomes the substrate for the action of aromatase enzyme which triggers conversion of biologically active estrogens [13].”
Background
Gastric bypass : positive and negative health effects
Backman, O. (2017) · Figshare
Integrated health original article Endometrial histology in severely obese bariatric surgery candidates: an exploratory analysis
Kaiyrlykyzy, A., Freese, K. E., Elishaev, E., Bovbjerg, D. H., Ramanathan, R. C., Hamad, G. G., McCloskey, C. A., Althouse, A. D., Huang, M. S., Edwards, R. P., et al. (2015)
Évaluation préopératoire des facteurs de risque de complications après chirurgie bariatrique
Quilliot, D., Sirveaux, M.-A., Nominé-Criqui, C., Fouquet, T., Reibel, N., & Brunaud, L. (2018) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2017.07.083
“[14] Crosbie EJ, Zwahlen M, Kitchener HC, et al.”
Background
Leitliniengerechtes Vorgehen beim Endometriumkarzinom
Domröse, C. M., & Mallmann, P. K. (2018) · gynäkologie + geburtshilfe · doi:10.1007/s15013-018-1312-6
Detection the level of YKL-40 biochemical marker and vitamin D level in sera of Iraqi Uterine cancer females' patients
Jasm, W., Farhan, A. R., & Abed, W. (2013) · Iraqi National Journal of Nursing Specialties · doi:10.58897/injns.v26i2.165
“((13)), confirms that BMI is strongly associated with an increased risk of incident endometrial cancer which extends our previous meta-analysis demonstrating that the association becomes stronger above BMI 27 kg/m(2), and that the association is particularly strong in women who have never been exposed to HRT.”
Background
Synchronous Endometrial Carcinoma and Adenosarcoma in Postmenopausal Patient: A Case Report
Sofoudis, C., Tsanakalis, E., Lenos, M. G., & Georgoulias, G. (2018) · Clinical Journal of Surgery · doi:10.33309/2639-9164.010104
MicroRNA-181a Suppresses Progestin-Stimulated Breast Cancer Cell Growth
Li, X., Yang, C., Ruan, X., Croteau, S., & Hardy, P. (2018) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2018/5.1147
Overweight, obesity and cancer risks
Ancellin, R., & Bessette, D. (2013) · ONCOLOGIE
Impact of TP53 polymorphisms (IVS3 + 40-41ins16, EX4 215G > C and IVS6 + 62G > A) on the risk of endometrial cancer, survival and hazard ratio of the patients
Nagam, S. L. S. S., & Jinka, R. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100684
Prevention of endometrial cancer with a healthier lifestyle: a review of the literature and proposal of the I.M.P.R.O.V.E. strategy
Pup, L. D., Buonomo, B., & Peccatori, F. A. (2020) · Cancer Reports and Reviews · doi:10.15761/crr.1000201
“For every 5 kg/m2 increase in Body Mass Index (BMI), there is a 60% increased risk of EC, with a BMI above 25 kg/m2 the risk is doubled and with a BMI above 30 kg/m2 the risk is tripled [11,12].”
Background
Comment justifier la chirurgie bariatrique chez les patients obèses ?
Rives‐Lange, C., Carette, C., & Czernichow, S. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75879-9.00001-9
Endometrial and Cervical Cancers
Incorvaia, L., Castellana, L., Insalaco, L., Maltese, G., & Lorusso, D. (2021) · UNIPA Springer series · doi:10.1007/978-3-030-56051-5_53
OBESITY AND ITS RELATIONSHIP WITH CANCER: PART II CANCER
Agarwal, S. K. (2021) · American International Journal of Cancer Studies · doi:10.46545/aijcs.v3i1.217
Differenzierter Einsatz von Gestagenen in der kombinierten Hormonersatztherapie – Einfluss auf das Mamma- und Endometriumkarzinomrisiko
Tempfer, C. M. (2022) · Gynäkologische Endokrinologie · doi:10.1007/s10304-022-00438-6
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Neel, B. A., Antoniou, I. M., & LeRoith, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_36-1
Bibliographies
(2020) · Springer Publishing Company eBooks · doi:10.1891/9780826173270.ap08
Epidemiologie, Risikofaktoren und Genetik des Endometriumkarzinoms
Tempfer, C. M., Steinke‐Lange, V., Aretz, S., Schmutzler, R. K., Ortmann, O., Römer, T., Hanf, V., Widhalm, S., Reents, N., Jud, S. M., et al. (2022) · Die Gynäkologie · doi:10.1007/s00129-022-04956-z
Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer
Ring, K. L., Pinkerton, J. V., Landrum, L. M., Zuna, R. E., & Duska, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77684-4.00013-1
Früherkennung, Risikofaktoren und Prävention des Endometriumkarzinoms
Tempfer, C. M. (2022) · Die Onkologie · doi:10.1007/s00761-022-01271-z
Data from Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts
Fuhrman, B. J., Moore, S. C., Byrne, C., Makhoul, I., Kitahara, C. M., de González, A. B., Linet, M. S., Weiderpass, E., Adami, H., Freedman, N. D., et al. (2023) · doi:10.1158/0008-5472.c.6512065
Data from Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts
Fuhrman, B. J., Moore, S. C., Byrne, C., Makhoul, I., Kitahara, C. M., de González, A. B., Linet, M. S., Weiderpass, E., Adami, H., Freedman, N. D., et al. (2023) · doi:10.1158/0008-5472.c.6512065.v1
Uterine Cervix and Corpus Cancers Characterization Through Gene Expression Analysis Using the KnowSeq Tool
Almorox, L., Herrera, L. J., Ortuño, F. M., & Rojas, I. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-34960-7_33
Therapie und Outcome gynäkologischer Tumore bei HIV-infizierten Patientinnen
Albrecht, N.-D. (2023) · doi:10.21248/gups.74696
Type I Endometrial Cancer: Early Stage
Parker, R. E. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-36179-1_16
Cancers of the Female Genital Tract
Perrone, A. M., Iaco, P. D., & Longhi, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-31307-3_4
Tumorerkrankungen und Hormone
Ortmann, O., Huber, D., & Tempfer, C. M. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_14
Predictive value of body mass index (BMI) and determination of optimum cut-off point in the diagnosis of endometrial hyperplasia in pre-menopausal women with abnormal uterine bleeding.
Garna, S. A., Yazdani, S., Musavi, H., Ranaei, M., Hajian‐Tilaki, K., & Bouzari, Z. (2024) · PubMed Central · doi:10.22088/cjim.15.1.9
A Case of Well-Differentiated Endometrial Adenocarcinoma in a Postmenopausal Woman
Shringi, S., Agrawal, A. K., Hiwale, K., & Gadkari, P. V. (2024) · Cureus · doi:10.7759/cureus.61070
“The etiology of endometrial adenocarcinoma is multifactorial, with obesity, unopposed estrogen therapy, nulliparity, late menopause, and diabetes mellitus identified as significant risk factors [14].”
Background
Characteristics of serum lipid metabolism in postmenopausal obese women and its effect on the proliferation, invasion and migration of endometrial cancer cellsPreprint
Zhang, J., Cao, Y., Kuang, L., Zheng, Y., Wang, M., Xu, H., Zhou, X., Liu, J., Wang, Q., Zhou, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4479633/v1
Trends in the incidence and mortality of cervical, ovarian, and corpus uteri cancers in Wales, UK: A joinpoint regression analysis from 2002 to 2021
Sekar, S., Budithi, S., & Fernando, S. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102660
Endometriumkarzinom: Risikofaktoren
Tempfer, C. M. (2025) · Die Gynäkologie · doi:10.1007/s00129-025-05340-3
Differential gene expression in uterine endometrioid cancer cells and adjusted normal tissue
Kodada, D., Hadžega, D., Krumpolec, P., Janoštiaková, N., Bľandová, G., Janega, P., Ballová, Z., Dosedla, E., Minárik, G., & Repiská, V. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102027
PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia
Lian, C., He, M., Zhao, C., Wang, T., Tong, F., Chen, J., & Ju, R. (2025) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2025.36.e84
“BMI increased 5 kg/m 2 conferring a 1.6-fold higher risk of EC [18].”
Influential
The causal association between ankylosing spondylitis and endometrial cancer: a two-sample mendelian randomization study
Gu, Y., & Shao, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-02399-1
“Women with a body mass index (BMI) over 40 kg/m 2 have a lifetime risk of developing EC ranging from 10 to 15%, a figure comparable to the lifetime risk of lung cancer in smokers [3].”
The effect of obesity on prognosis in patients with endometrioid type endometrial adenocarcinoma
Gül, Ö., & Demirağ, G. (2025) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1658483
Differential triage in the postmenopausal bleed clinic; getting it right the first time, effect on single cancer pathway
Gokhale, L., Edwards, C. B., & Jones, T. (2025) · Post Reproductive Health · doi:10.1177/20533691251355846
“20 In Europe, excess body weight has been estimated to account for 60% of all new EC cases per year.”
Einfluss endogener und exogener Hormone in der Peri- und Postmenopause auf das Krebsrisiko
Schüler‐Toprak, S., Bausewein, L., & Ortmann, O. (2025) · Die Onkologie · doi:10.1007/s00761-025-01820-2
A lipid metabolism and lysosome-based risk signature for prognosis and immune response prediction in uterine corpus endometrial carcinoma
Zhu, Y., Yang, P., & Zhang, S. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1594682
“Endometrial cancer shows the strongest association with obesity compared to other common malignancies (Crosbie et al., 2010).”
Assessing How Obesity Affects the Risk of Endometrial Cancer
Nagah, A., & Liu, X. (2025) · Nutrition and Cancer · doi:10.1080/01635581.2025.2598922
“According to Crosbie et al. (10), being overweight is a major contributing factor to the evolution of endometrial tumors.”
Additional file 2 of Lipid profile and risk of ovarian tumours: a meta-analysis
Onwuka, J. U., Okekunle, A. P., Olutola, O. M., Akpa, O. M., & Feng, R. (2020) · Figshare · doi:10.6084/m9.figshare.11979114
Additional file 3 of Mendelian randomization analysis of factors related to ovulation and reproductive function and endometrial cancer risk
D’Urso, S., Arumugam, P., Weider, T., Hwang, L., Bond, T. A., Kemp, J. P., Warrington, N. M., Evans, D. M., O’Mara, T. A., & Moen, G.-H. (2022) · Figshare · doi:10.6084/m9.figshare.21455960

Authors: Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G.
Affiliations: University of Bern (CH)
ORCID: Crosbie, Emma J.
Zwahlen, Marcel
Kitchener, Henry C.
Egger, Matthias
Renehan, Andrew G.
Venue: Cancer Epidemiology, Biomarkers & Prevention
Publisher: American Association for Cancer Research (AACR)
Published: 2010-12-01
Volume: 19
Issue: 12
Pages: 3119-3130
ISSN: 1055-9965 (ISSN-L)
1538-7755
DOI: 10.1158/1055-9965.epi-10-0832
OpenAlex: W2076975509
Cited by: 321
References: 85
Citations by year: 2026: 21 · 2025: 19 · 2024: 15 · 2023: 24 · 2022: 25 · 2021: 25 · 2020: 26 · 2019: 15 · 2018: 19 · 2017: 20 · 2016: 21 · 2015: 33 · 2014: 23 · 2013: 21 · 2012: 9
FWCI: 1.18
Type: journal article
Language: en
Open access: closed
Locations: Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion)
BORIS (University Library Bern) (submittedVersion)
Funders: National Institute for Health and Care Research (CL-2007-06-005)
Topics: Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords: body mass index, endometrial cancer, hormone replacement therapy, obesity, menopausal status, histological subtypes, cancer risk modification, dose-response relationship, postmenopausal women, endometrial hyperplasia, endometrial adenocarcinoma, endometrioid carcinoma, serous carcinoma
MeSH terms: Female, Humans, Risk Factors, Cohort Studies, Body Mass Index, Endometrial Neoplasms, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks